IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPolitics

AbbVie Blood Cancer Therapy Succeeds

AbbVie announced that its blood cancer therapy etentamig met the main goals of a late stage trial by reducing the risk of disease progression and death. The treatment showed strong results in patients with refractory multiple myeloma.

Xurve View
Insights:

Related News
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 - 1205 , Cayman Islands

Copyright IUX24 Media LTD. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and intelligence platform. This site provides market news and analytical data only; it does not constitute investment advice, individual trading signals, or brokerage services. All information is for educational and informational purposes. Trading involves significant risk, and we recommend consulting with a qualified financial professional before making any investment decisions.